A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Clinical trial NCT03748641 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03748641
Sponsor: Janssen Research & Development, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Castration-Resistant Prostatic Cancer

Start date: 2019-01-25
Primary completion: 2021-10-08
Enrollment: 765

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.